This study investigates unresectable locally advanced pancreatic cancer. It focuses on gathering information about a specific device used in treatment.
The study evaluates the performance and safety of the device in real-world settings. It collects data from patients using the device in combination with a type of chemotherapy.
- Who can participate: Adults aged 18 and older with unresectable locally advanced pancreatic cancer are eligible.
- Study details: Participants will use a specific device along with chemotherapy.
- Study timelines: The study will last 7 years.